Approval · Notice of Compliance 1269 · 2000
PLAN B: Notice of Compliance 1269
Issued February 9, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1269
- Date
- February 9, 2000
- Company
- Womens Capital Corporation
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
- Therapeutic class
- Emergency contraception
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PLAN B | 02241674 | Cancelled Post Market |
Medicinal ingredients
- LEVONORGESTREL 0.75 MG per TAB